TSE:TLB

TearLab (TLB) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
C$0.33
C$0.33
52-Week Range
N/A
Volume
35,660 shs
Average Volume
21,586 shs
Market Capitalization
C$3.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About TearLab

TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

TLB Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive TLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TearLab and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$3.37 million
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Elias Vamvakas (Age 58)
    Chairman of the Board
  • Joseph S. Jensen (Age 45)
    President, Chief Executive Officer, Chief Operating Officer, Director
  • Wes Brazell (Age 51)
    Chief Financial Officer
  • Anthony E. Altig (Age 61)
    Independent Director
  • Paul M. Karpecki (Age 49)
    Independent Director
  • Richard L. Lindstrom M.D. (Age 69)
    Independent Director

TLB Stock Analysis - Frequently Asked Questions

How do I buy shares of TearLab?

Shares of TLB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:TLB) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners